Commercially available kits (Mycobacterium avium Complex Rapid Diagnostic System and Mycobacterium tuberculosis Complex Rapid Diagnostic System; Gen-Probe, Inc., San Diego, Calif.) utilizing nucleic acid hybridization for the rapid identification of members of the M. avium-M. intracellulare complex and M. tuberculosis complex were evaluated by using 339 clinical and American Type Culture Collection (Rockville, Md.) [1251]DNA-RNA hybrids are then counted, and test results are calculated as the percentage of input probe hybridized. The Gen-Probe system has been shown to be a rapid and accurate procedure for the identification of M. avium-M. intracellulare from growth on agar medium and sediments from BACTEC 12B bottles (Johnston Laboratories, Inc., Towson, Md.) (1-3). The sensitivity of the system has been shown, but specificity has not been well demonstrated.
The detection and identification of mycobacteria in clinical specimens often require several weeks before results are available. Rapid methods would make clinically useful information available sooner within a clinically relevant period of time, in contrast to conventional methods. Nucleic acid probe technology for identification of mycobacterial cultures is relatively rapid and simple to use. It would make the use of conventional biochemical tests unnecessary for some isolates and give all laboratories the capability to identify such isolates.
Rapid detection and identification of Mycobacterium avium-M. intracellulare complex are particularly important, because these organisms are a major cause of disease in immunocompromised patients and since therapy differs from that used for other mycobacterial diseases. In many laboratories, M. avium-M. intracellulare complex is the most frequently recovered species.
The Rapid Diagnostic System kits for M. aiium complex and M. tuberculosis complex (Gen-Probe, Inc., San Diego, Calif.) employ nucleic acid hybridization assays based on the ability of complementary nucleic acid strands to bond and form stable double-stranded complexes under appropriate test conditions. An '25I-labeled single-stranded DNA probe complementary to the rRNA of the target organism is used. The rRNA is released from the test organism through the action of a lysing reagent, heat, and sonication. The to a turbidity equivalent to a no. 1 McFarland barium sulfate nephelometer standard. The suspensions were stored at 2 to 8°C and tested within 24 h, although the suspensions can be held for up to 72 h before testing. For each isolate, 100 pul of bacterial suspension was added to a tube of lysing reagent and sonicated for 15 min at 50 to 70°C in a water bath sonicator. The tube was removed from the sonicator, 1.0 ml of probe solution was added, and the contents of the tube were vortexed to mix thoroughly and incubated for 1 h at 72 ± 1°C in a water bath. The tube was removed from the water bath, 4.0 ml of separation suspension was added, and the tube was inverted slowly 20 times to mix thoroughly and incubated for 5 min at 72 ± 1°C in a water bath. The tube was removed from the water bath, inverted 20 times to completely resuspend the pellet, and centrifuged at 500 to 3,000 x g for 2 min, and the supernatant was decanted. Wash solution (4 ml) was added to the tube, which was then vortexed for 20 s, inverted slowly 20 times to completely resuspend the pellet, and centrifuged at 500 to 3,000 x g for 2 min. The supernatant was then decanted, and the tube was drained completely. The preceding procedure was performed with each of the three probes with every isolate. Positive and negative controls were done with each run by using M. tuberculosis ATCC 25177, M. avium ATCC 25291, and M. intracellulare ATCC 13950. Each tube was counted in a gamma counter for 1 min, and the percent hybridization was calculated as follows: percent hybridization = [(sample cpm -background cpm)/(total cpm of input probe -background cpm)] x 100, in which cpm is counts per minute. A percent hybridization greater than or equal to 10 was considered positive. A valid negative control was less than 5% of the total input count, and a valid positive control was greater than 20% of the total input count. Organism identifications obtained by probe testing were compared with identifications obtained by using standard methods. kansasii were nonreactive with the probe. Our study resulted in similarly highly sensitive and specific results. The sensitivities of the M. avium-M. intracellulare probes before and after repeat testing were 93.4 and 96.5%, respectively, and the specificities before and after repeat testing were 96.6 and 100%, respectively. The predictive values of positive and negative tests with the M. avium-M. intracellulare probes were 92.5 and 97.0%, respectively. The M. tuberculosis complex probe was even more sensitive and specific, yielding sensitivities before and after repeat testing of 99 and 100%, respectively, and a specificity of 99.2% both before and after repeat testing. The predictive values of positive and negative tests with the M. tuberculosis complex probe were 98.0 and 99.6%, respectively. Of the 15 discrepant M. avium-M. intracellulare results, 8 were discrepant because the isolates reacted with both M. avium-M. intracellulare probes. However, the results would not have changed decisions concerning therapy. The identifications of all eight were resolved upon repeat testing. Of the seven remaining discrepant M. avium-M. intracellulare results, seven isolates (specimens 242, 543, 573, 620, 626, 629, and 760) initially did not react with either M. avium-M. intracellulare probe. Three of the seven isolates, however, did have borderline probe results (specimen 573, 8.8% hybridization with the M. intracellulare probe; specimen 620, 9.8% hybridization with the M. avium probe; and specimen 629, 9.5% hybridization with the M. intracellulare probe). These results might prompt repeat probe testing which, for three isolates, resulted in an identification. The M. avium-M. intracellulare isolates and one M. tuberculosis isolate (specimens 242, 543, 626, 760, and 264) having very low percent hybridization values for the three probes on original testing may remain a problem, because they probably would not be routinely retested and would most likely have to be subjected to standard biochemical tests in order to be identified. Therefore, it would be necessary to have reagents available for the identification of such isolates if a laboratory wanted to provide that level of service.
RESULTS
The Differentiation of M. avium-M. intracellulare isolates into M. avium and M. intracellulare species is not necessary for determining optimal therapy; therefore, we feel that it would be more cost-effective to combine these two probes into one pool. In addition, if each kit contained both the M. tuberculosis complex probe and a pooled M. avium-M. intracellulare probe, it would be more convenient and probably less costly to use.
Factors for a laboratory considering the use of probes for the identification of mycobacteria include obtaining approval to use radionuclides, the cost-effectiveness of the probes (which is largely dependent upon both the volume and positivity rate of mycobacterial cultures performed in a particular laboratory), and the feasibility of incorporating the probes into the laboratory workflow. The M. tuberculosis kit contains enough nucleic acid probe to identify 18 isolates, including controls. The M. avium complex kit contains enough reagents to perform 20 assays; however, each isolate requires an M. avium and M. intracellulare probe assay. Therefore, only eight isolates can be identified. Each kit is available at a cost of $200.00 and has a shelf life of 1 month. One M. tuberculosis control kit and two M. avium complex kits are required for complete testing of 18 isolates if each isolate is tested with all three probes. Therefore, the most cost-effective manner to use a single kit to test unknown mycobacterial isolates is to test 18 isolates simultaneously at a cost of $33.33 per isolate, not including labor or additional equipment needed (e.g., water bath sonicator, centrifuge, and gamma counter). The least cost-effective way to use a single kit is to perform six separate test runs (testing one isolate) at a cost of $100.00 per isolate, again not including labor or equipment. In addition, the procedure requires approximately 2 h if a low number of isolates are tested; however, if many isolates are tested with all three probes, the procedure requires a much longer period of time. It may be possible to selectively use one or more of the probes for identification after screening an isolate on the basis of growth rate and colony morphology.
In summary, the probes are highly sensitive and specific for use in rapidly identifying M. avium-M. intracellulare complex and M. tuberculosis complex isolates and will be useful in the clinical laboratory which has the volume to use the present radionuclide-containing kits cost-effectively.
